Constant references to “expensive” medicines and wrongful comparisons between the private sector prices in Cyprus and prices of other countries with comprehensive health systems, paint a distorted picture of medicine prices in Cyprus. The Cyprus Association of...
The implementation of a modern and sustainable healthcare system, which will guarantee the provision of top-level health services and at the same time enable equitable access to innovative medicines for all patients, was the subject of discussion in a meeting between...
Stricter provisions on the promotion of prescription medicines to healthcare professionals are among others points included in the revised Code of Practice by the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA). The new Code, which has...
*By Joanna Kozakou States are under unprecedented pressure to achieve the correct balance between universal access to high quality Health services and adhering to budgetary constraints. As the European Union’s Commissioner for Health and Consumer Policy, Tonio Borg,...
Joanna Kozakou, Operations Manager of Sanofi, has assumed the position of President of the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA), following the departure of Daan Gijbels from Cyprus who will undertake a new position as Area...
